At present, the US new crown vaccine , the cost of testing and treatment is basically borne by the federal government, but soon, the US government will require individuals to bear this part of the cost.
The United States is now in a state of public health emergency, and health care now works more similarly to other high welfare countries. But when the public health emergency ends, it will restore the way health care operations in the United States, when the expenses of people with commercial health insurance will be paid by medical reimbursement, and the federal government with low income without commercial insurance will pay this part of the expenses.
The US Medicare and Medicaid Service Center told medical providers as early as August that they began to prepare to resume the way they operated before COVID-19 as soon as possible. Although White House has been urging Congress to provide billions of dollars in funding to cover the cost of supplying COVID-19 vaccines and treatments, Congress members do not support it.
After the days of the free COVID-19 test, private insurance may no longer cover over-the-counter tests, so patients may need to see a doctor first before they can get the test. This may cause many people to not test if they are positive for , which will increase the spread of the epidemic. In addition, although people with private insurance can still get vaccinated for free, premiums will increase as a result. Moreover, Americans who are not insured or underinsured may be more affected, resulting in the inability to receive timely treatment for the new crown.
At the same time, without the participation of the federal government, pharmaceutical companies may charge high fees for COVID-19 vaccines and treatments. Pfizer has said that once the government contract ends early next year, the cost of its COVID-19 vaccine will be quadrupled, with charges of up to $110 to $130 per dose. Meanwhile, Eli Lilly's monoclonal antibody therapy currently has up to $2,100 per dose. As prices rise, even Americans with private insurance may face the challenge of choosing treatment. By then, more Americans will not be treated, which will further increase the number of COVID-19 infections and deaths.
